No individual can be first author on more than one abstract. All submitted abstracts must be sponsored by a member of CPDD. Fellows, Regular, or Corporate Members can sponsor an unlimited number of abstracts, their own as well as those of others. Associate Members can sponsor any abstracts on which they are listed as an author. Members-In-Training can submit one abstract on which they are first author but cannot sponsor any other abstracts. Should you need a list of members, please contact the Executive Office of CPDD. You need to get permission from the potential sponsor before listing him/her, and you should provide a copy of the abstract to the sponsor. The character limit is 2300 for the text of the abstract. This includes the title, authors, institutions and all spaces and carriage returns.
Papers can be on any aspect of drug abuse or addiction or on the actions of drugs of abuse. They should contribute to our knowledge of the agents involved in drug abuse, including their molecular biology, chemistry, pharmacological action, biological disposition, abuse potential, safety or clinical usefulness. Contributions concerning research on neurobiology, epidemiology, prevention, public health aspects, or management and treatment of drug dependence also are encouraged.
Procedures for Submission
There are four categories of abstract submissions: Original Research, Program Descriptions, Theoretical/Commentary, and Literature Review. All categories must include an Aim, a Conclusion and a “Supported by” statement. Original Research must include Methods and Results sections. These sections are optional for the other categories. Details of each category are provided below.
Original Research includes all prospective and retrospective studies that involve testing a hypothesis by collecting and analyzing data. Abstracts of basic research or clinical studies must specify the following: hypothesis, species, number of subjects, procedures, results, statistical analyses, and importance of findings (conclusions). Scholarly historical or sociological reports must specify hypothesis, procedures, analyses, results, and a concluding statement describing the implications of the study. Please note that results must be explicitly described in the abstract, and that abstracts reporting no results likely will be rejected. Recently completed studies, as yet unpublished, are preferred and any in press work must have a publication date after July 1, 2013.
Program Descriptions are reserved for non-experimental abstracts that simply provide a narrative of a research program or a theme that is being pursued. No data are required; however, this category should not be used to describe ongoing original research for which there currently are no data. Rather, these abstracts should describe programs or themes that are not based upon hypothesis-driven research.
Theoretical/Commentary abstracts can be about any topic related to drug abuse, including (but not limited to) policy, trends in the field, treatment strategies, mechanisms of action, and methodological issues. No data are required.
Literature Review abstracts should provide a scholarly discussion of a specific topic via a review of the current literature. Critical review abstracts need not have data per se but will need to have a concluding statement about the authors’ findings.
All submissions will be peer-reviewed, and time, space, and programmatic needs will be considered in decisions of acceptance or rejection, and in assignment to oral or poster sessions. First authors will receive e-mail notification of acceptance with the date and time of presentation. No individual can be first author on more than one abstract. Abstracts will be available for viewing and downloading at cpdd.org before the meeting.
Use the Electronic Abstract Submission link to submit abstracts for the 2013 CPDD Annual Meeting. Follow the online instructions given for each page.
The abstract fee of $50.00 is payable by credit card. Abstracts submitted for oral or poster sessions must be entered by December 3, 2012. Please read the abstract guidelines and follow the instructions carefully. Failure to follow the instructions will result in rejection of your abstract.